Delivery Order SPE2DB24D1021-SPE2DB25FEWUB
Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,059.76 to AmerisourceBergen Drug Corp for the supply of Multaq (dronedarone) 400 mg tablets in a 60-count package. This non-set-aside, firm fixed-price delivery order was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Multaq is an antiarrhythmic medication used to treat atrial fibrillation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,550.46 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Multaq (dronedarone) is an antiarrhythmic medication used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Multaq (dronedarone) 400 mg tablets in quantities of 60 units. This firm fixed-price delivery order has a ceiling value of $19,914.33 and an ultimate completion date of September 11, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Multaq is an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,060.55 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This firm fixed-price, competitively awarded delivery order was issued on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,529.88 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units, valued at $4,506.52. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,337.56. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 25, 2025. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the pharmaceutical distributor's role in supplying critical medications to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq (dronedarone) 400 mg tablets in a quantity of 60 units, valued at $2,947.88. This competitive award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, utilizes firm fixed pricing under a non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $1,871.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Multaq 400 mg tablets (60-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $19,665.68 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). The contract, which is a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. Multaq is an antiarrhythmic medication used in military and veteran healthcare systems,...